Contact this trialFirst, we need to learn more about you.
PCSK9 Inhibitor
Enlicitide Decanoate for High Cholesterol
Recruiting1 awardPhase 3
Lincoln, California
This trial aims to see if a new medication, enlicitide decanoate, is better than current treatments like ezetimibe or bempedoic acid in lowering LDL cholesterol levels in people
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service